-transparent.png){kind=logo}
The presence of androphilic protein identified histochemically with R 1881-CMO-BSA-FITC correlated with response to endocrine therapy and prognosis. Ras P21 was not a useful indicator of the subsequent course of the disease. Conventional X ray assessment of boney metastases still seems of use in monitoring overall progress of the disease.
Related Publications
J Shimazaki, and
S Isaka, and
S Akimoto, and
H Sumiya, and
M Masai, and
T Higa
November 1983,
Seminars in urology,
J Shimazaki, and
S Isaka, and
S Akimoto, and
H Sumiya, and
M Masai, and
T Higa
January 1981,
Lancet (London, England),
J Shimazaki, and
S Isaka, and
S Akimoto, and
H Sumiya, and
M Masai, and
T Higa
February 1982,
Lancet (London, England),
J Shimazaki, and
S Isaka, and
S Akimoto, and
H Sumiya, and
M Masai, and
T Higa
July 1985,
Gan no rinsho. Japan journal of cancer clinics,
J Shimazaki, and
S Isaka, and
S Akimoto, and
H Sumiya, and
M Masai, and
T Higa
April 1982,
Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
J Shimazaki, and
S Isaka, and
S Akimoto, and
H Sumiya, and
M Masai, and
T Higa
January 1993,
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
J Shimazaki, and
S Isaka, and
S Akimoto, and
H Sumiya, and
M Masai, and
T Higa
December 1958,
British journal of urology,
J Shimazaki, and
S Isaka, and
S Akimoto, and
H Sumiya, and
M Masai, and
T Higa
March 1990,
Bailliere's clinical endocrinology and metabolism,
J Shimazaki, and
S Isaka, and
S Akimoto, and
H Sumiya, and
M Masai, and
T Higa
July 1980,
Clinics in endocrinology and metabolism,
J Shimazaki, and
S Isaka, and
S Akimoto, and
H Sumiya, and
M Masai, and
T Higa
February 1953,
The Journal of clinical endocrinology and metabolism,
